• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement.

作者信息

Rajendran Judah, Ramu Shivabalan Kathavarayan, Khuttan Akhilesh, Besir Besir, Lomaia Tamari, Nasif Danial, Pandya Krutarth, Bandari Vishalraj, Yun James, Harb Serge, Reed Grant, Krishnaswamy Amar, Puri Rishi, Kapadia Samir R

机构信息

Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.

出版信息

J Soc Cardiovasc Angiogr Interv. 2025 May 2;4(7):103658. doi: 10.1016/j.jscai.2025.103658. eCollection 2025 Jul.

DOI:10.1016/j.jscai.2025.103658
PMID:40933098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12418398/
Abstract
摘要

相似文献

1
Management of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术患者冠状动脉疾病的管理
J Soc Cardiovasc Angiogr Interv. 2025 May 2;4(7):103658. doi: 10.1016/j.jscai.2025.103658. eCollection 2025 Jul.
2
Transcatheter Versus Surgical Approach for the Treatment of Aortic Stenosis in Patients With Concomitant Coronary Artery Disease: A Systematic Review and Meta-Analysis.经导管与外科手术治疗合并冠状动脉疾病的主动脉瓣狭窄患者：系统评价与荟萃分析
Catheter Cardiovasc Interv. 2025 Jul 1. doi: 10.1002/ccd.31697.
3
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve replacement: A network meta-analysis.经导管主动脉瓣置换术患者行经皮冠状动脉介入治疗的最佳时机：一项网状荟萃分析。
Cardiovasc Revasc Med. 2025 Jul;76:56-63. doi: 10.1016/j.carrev.2025.03.007. Epub 2025 Mar 6.
4
Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta-Analysis.经导管主动脉瓣植入术联合或不联合经皮冠状动脉血运重建策略：一项系统评价与荟萃分析
J Am Heart Assoc. 2017 Jun 27;6(6):e005960. doi: 10.1161/JAHA.117.005960.
5
Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic review and meta-analysis.经导管主动脉瓣置换术和经皮冠状动脉介入治疗与外科主动脉瓣置换术和冠状动脉旁路移植术治疗重度主动脉瓣狭窄合并冠状动脉疾病患者的比较：系统评价和荟萃分析。
Catheter Cardiovasc Interv. 2020 Nov;96(5):1113-1125. doi: 10.1002/ccd.29110. Epub 2020 Jul 14.
6
Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.主动脉瓣狭窄与冠状动脉疾病：外科手术与经导管治疗的决策制定
Circulation. 2024 Dec 17;150(25):2046-2069. doi: 10.1161/CIRCULATIONAHA.124.070502. Epub 2024 Dec 16.
7
Protected complex percutaneous coronary intervention and transcatheter aortic valve replacement using extracorporeal membrane oxygenation in a high-risk frail patient: a case report.高危体弱患者采用体外膜肺氧合进行受保护的复杂经皮冠状动脉介入治疗和经导管主动脉瓣置换术：一例报告
J Med Case Rep. 2020 Sep 23;14(1):163. doi: 10.1186/s13256-020-02474-x.
8
The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.经导管主动脉瓣置换术患者中慢性完全闭塞的影响：一项系统评价和荟萃分析。
Catheter Cardiovasc Interv. 2023 Mar;101(4):806-812. doi: 10.1002/ccd.30601. Epub 2023 Feb 19.
9
Co-Occurrence of Aortic Stenosis and Coronary Artery Disease: Facing Challenges Before, During, and After Transcatheter Aortic Valve Replacement.主动脉瓣狭窄与冠状动脉疾病的共病：经导管主动脉瓣置换术前、术中和术后面临的挑战
J Clin Med. 2025 Jul 3;14(13):4709. doi: 10.3390/jcm14134709.
10
Coronary Events After Transcatheter Aortic Valve Replacement: Insights From the France TAVI Registry.经导管主动脉瓣置换术后的冠状动脉事件：来自法国经导管主动脉瓣置换术注册研究的见解
JACC Cardiovasc Interv. 2025 Jan 27;18(2):229-243. doi: 10.1016/j.jcin.2024.09.005.

本文引用的文献

1
Timing and Outcomes of PCI in Conjunction With TAVR With Balloon-Expandable Valves.经皮冠状动脉介入治疗（PCI）联合使用球囊扩张瓣膜的经导管主动脉瓣置换术（TAVR）的时机与结果
JACC Cardiovasc Interv. 2025 Jan 27;18(2):244-254. doi: 10.1016/j.jcin.2024.10.055.
2
Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.未经治疗的慢性阻塞性冠状动脉疾病对经导管主动脉瓣置换术后结局的影响。
Eur Heart J. 2024 Jun 1;45(21):1890-1900. doi: 10.1093/eurheartj/ehae019.
3
Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.经导管主动脉瓣植入术患者同期行经皮冠状动脉介入治疗。
Catheter Cardiovasc Interv. 2024 Jan;103(1):186-193. doi: 10.1002/ccd.30927. Epub 2023 Dec 22.
4
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery.经导管主动脉瓣植入术患者的冠状动脉疾病管理。欧洲经皮心血管介入协会与 ESC 心血管外科学工作组合作的临床共识声明。
EuroIntervention. 2023 May 15;19(1):37-52. doi: 10.4244/EIJ-D-22-00958.
5
Concomitant percutaneous coronary intervention and transcatheter aortic valve replacement: safe and feasible replacement alternative approaches in high-risk patients with severe aortic stenosis and coronary artery disease.同期经皮冠状动脉介入治疗与经导管主动脉瓣置换术：重度主动脉瓣狭窄合并冠状动脉疾病高危患者安全可行的替代置换方法。
J Card Surg. 2013 Sep;28(5):481-3. doi: 10.1111/jocs.12176. Epub 2013 Jul 21.